PARKSIDE PHARMACY LIMITED

PARKSIDE PHARMACY LIMITED

PARKSIDE PHARMACY LIMITED - Company Information

Print Friendly Version

PARKSIDE PHARMACY LIMITED

Company Registration Number:
04771472 (England and Wales)

Unaudited abridged accounts for the year ended 30 June 2018

Period of accounts

Start date: 01 July 2017

End date: 30 June 2018

PARKSIDE PHARMACY LIMITED

Contents of the Financial Statements

for the Period Ended 30 June 2018

Balance sheet
Notes

PARKSIDE PHARMACY LIMITED

Balance sheet

As at 30 June 2018


Notes
2018
2017


£
£
Fixed assets
Intangible assets: 3 50,000 60,000
Tangible assets: 4 133,352 109,518
Total fixed assets: 183,352 169,518
Current assets
Stocks: 30,000 30,000
Debtors:   251,565 150,650
Cash at bank and in hand: 381,780 391,757
Total current assets: 663,345 572,407
Creditors: amounts falling due within one year: 5 (150,156) (154,071)
Net current assets (liabilities): 513,189 418,336
Total assets less current liabilities: 696,541 587,854
Creditors: amounts falling due after more than one year: 6 (86,317) (70,342)
Provision for liabilities: (1,632) (2,790)
Total net assets (liabilities): 608,592 514,722
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 608,590 514,720
Shareholders funds: 608,592 514,722

The notes form part of these financial statements

PARKSIDE PHARMACY LIMITED

Balance sheet statements

For the year ending 30 June 2018 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 08 November 2018
and signed on behalf of the board by:

Name: Mr S Nair
Status: Director

The notes form part of these financial statements

PARKSIDE PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2018

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

PARKSIDE PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2018

2. Employees

2018 2017
Average number of employees during the period 8 9

PARKSIDE PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2018

3. Intangible Assets

Total
Cost £
At 01 July 2017 200,000
At 30 June 2018 200,000
Amortisation
At 01 July 2017 140,000
Charge for year 10,000
At 30 June 2018 150,000
Net book value
At 30 June 2018 50,000
At 30 June 2017 60,000

PARKSIDE PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2018

4. Tangible Assets

Total
Cost £
At 01 July 2017 157,191
Additions 35,386
At 30 June 2018 192,577
Depreciation
At 01 July 2017 47,673
Charge for year 11,552
At 30 June 2018 59,225
Net book value
At 30 June 2018 133,352
At 30 June 2017 109,518

PARKSIDE PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2018

5. Creditors: amounts falling due within one year note

The bank loan is secured by way of a fixed and floating charge over all assets of the company amounting to £2,187 (2017 £2,105)

PARKSIDE PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2018

6. Creditors: amounts falling due after more than one year note

The bank loan is secured by way of a fixed and floating charge over all the assets of the company amounting to £60,983 (2017 £63,155).included within creditors more than one year is an amount of £52,237 (2017 £54,734) in respect of liabilities payable or repayable by instalments which fall fue foe payment after more than five years from the reporting date.As part of the financing of the property acquisition the company has received a term loan with monthly repayments amounting to £316.75 with interest charged at 2.5%.

PARKSIDE PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2018

7. Loans to directors

Name of director receiving advance or credit: Mr S Nair
Description of the loan: The loan is interest free and repayable on demand.
£
Balance at 01 July 2017 5,485
Advances or credits made: 26,277
Advances or credits repaid: 31,762
Balance at 30 June 2018 0

During the year a management charge of £18,000 (2017 £18,000) was paid to the parent company Parkside Pharmacare Limited.During the year the company paid dividends of £39,000 (2017 £36,000) to Parkside Pharmacare Limited.At 30/6/18 the company was owed £166,532 (2017 £60,944) from Parkside Pharmacare Limited.

PARKSIDE PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2018

8. Related party transactions

Name of the related party: Parkside Pharmacare Limited
Relationship:
Parent Company
Description of the Transaction: See previous notes regarding dividends, management charges and inter group loans.
£
Balance at 01 July 2017 60,944
Balance at 30 June 2018 166,532